Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 959Glioblastoma 299Gliosarcoma 288Osteosarcoma 285Brain Neoplasms 195Dendritic Cell Sarcoma, Interdigitating 188Gastrointestinal Stromal Tumors 180Bone Neoplasms 172Lymphoma 160Central Nervous System Neoplasms 160Astrocytoma 155Sarcoma, Ewing 150Glioma 148Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Lymphoma, Non-Hodgkin 143Burkitt Lymphoma 139Neoplasms 137Recurrence 134Lymphoma, Large B-Cell, Diffuse 128Lymphoma, Follicular 128Neuroblastoma 126Rhabdomyosarcoma 125Hodgkin Disease 124Oligodendroglioma 123Breast Neoplasms 123Lymphoma, Mantle-Cell 117Leukemia, Myeloid, Acute 117Leukemia, Lymphocytic, Chronic, B-Cell 117Lymphoma, B-Cell, Marginal Zone 113Leukemia 111

Interventions

tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Inhibition, Psychological × Sarcoma × Clear all
NCT04917042 2026-06-04

Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

University of Florida

Phase 2 Active not recruiting
10 enrolled 12 charts
Sarcoma

Inhibition, Psychological, Sarcoma, Nerve Sheath Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡